Inspiration Healthcare Group PLC
LSE:IHC

Watchlist Manager
Inspiration Healthcare Group PLC Logo
Inspiration Healthcare Group PLC
LSE:IHC
Watchlist
Price: 25.2 GBX Market Closed
Market Cap: £22.6m

Inspiration Healthcare Group PLC
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Inspiration Healthcare Group PLC
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Inspiration Healthcare Group PLC
LSE:IHC
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Research & Development
-$296m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Research & Development
-$185.8m
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
-16%
EKF Diagnostics Holdings PLC
LSE:EKF
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EMV Capital PLC
LSE:EMVC
Research & Development
-£1.1m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
13%
No Stocks Found

Inspiration Healthcare Group PLC
Glance View

Market Cap
22.6m GBX
Industry
Health Care

Inspiration Healthcare Group Plc engages in the provision of medical technology for critical care, operating theatre, and other medical applications. The company is headquartered in Crawley, West Sussex and currently employs 149 full-time employees. The company went IPO on 2001-12-14. The company provides products to patients around the world, which help to improve patient outcomes, and it invests in product opportunities and disruptive technologies. The company operates through its three subsidiaries, Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd. Under these brands it sells neonatal intensive care and operating theatre equipment around the world through a network of distributors into approximately 75 countries. The company also acts as a distributor for third party companies, which want to access the United Kingdom and the Republic of Ireland’s health systems using its sales and service of these healthcare providers. The company distributes its products to the various therapy areas, including infusion, respiratory and developmental care. The company operates through a single business segment, Critical Care Medical Devices.

IHC Intrinsic Value
HIDDEN
Show

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett